Close Get Latest Internet Explorer Get Latest Firefox Get Latest Chrome

Our Team

John Niederhuber, MD

John Niederhuber, MD
Chief Executive Officer
 Inova Translational Medicine Institute

Dr. Niederhuber brings a lifetime of medical knowledge, large organization management experience and vision to his position as CEO, including his most recent tenure as director of the National Cancer Institute (NCI). A nationally renowned surgeon and researcher, he has dedicated his four-decade career to the treatment and study of cancer. He has served as professor, cancer center director, National Cancer Advisory Board chair, external advisor to NCI, grant reviewer, and laboratory investigator supported by NCI and National Institutes of Health.

Dr. Niederhuber previously served as NCI's chief operating officer and deputy director for translational and clinical sciences and chair of the National Cancer Advisory Board (NCAB). He remains involved in research at his laboratory on the National Institutes of Health (NIH) campus.

As a surgeon, Dr. Niederhuber's clinical emphasis is on gastrointestinal cancer, hepatobiliary (liver, bile duct, and gallbladder) and breast cancers. He is recognized for his pioneering work in hepatic artery infusion chemotherapy and was the first to demonstrate the feasibility of totally implantable vascular access devices.

Dr. Niederhuber is a member of the Institute of Medicine of the National Academy of Science and has received numerous honors and awards.


Joe Vockley, PhD

Joe Vockley, PhD
Chief Operating Officer and Chief Scientific Officer
Inova Translational Medicine Institute

Dr. Vockley brings 25 years of experience in academic, pharmaceutical, biotechnology CROs and government research to his roles as COO and CSO. He has vast expertise is in the fields of genetics, genomics, molecular diagnostics, bioinformatics and large program management.

Dr. Vockley is an operations-oriented manager and scientist. He is inventor on numerous US and international genomic and bioinformatic patents in the areas of DNA diagnostics, laboratory methods for microarray analysis, gene discoveries and bioinformatic tool development. His basic research interests are in the fields of cancer and inborn errors of metabolism.

Dr. Vockley has previously held the positions of chief scientific officer, vice president of research, director of genomics and director of bioinformatics. He was the director of National Cancer Institute's Cancer Genome Atlas project and the Cancer Genome Atlas Program office.